A Phase 1 Study of AV-380 in Healthy Subjects

NCT04815551 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Cachexia

Interventions

DRUG: AV-380
DRUG: Placebo

Sponsor

AVEO Pharmaceuticals, Inc.